135 related articles for article (PubMed ID: 27103625)
1. Predictors of mortality within 1 year after primary ovarian cancer surgery: a nationwide cohort study.
Ørskov M; Iachina M; Guldberg R; Mogensen O; Mertz Nørgård B
BMJ Open; 2016 Apr; 6(4):e010123. PubMed ID: 27103625
[TBL] [Abstract][Full Text] [Related]
2. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
3. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer.
Chang SJ; Bristow RE; Ryu HS
Ann Surg Oncol; 2012 Dec; 19(13):4059-67. PubMed ID: 22766983
[TBL] [Abstract][Full Text] [Related]
4. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.
Aletti GD; Dowdy SC; Gostout BS; Jones MB; Stanhope CR; Wilson TO; Podratz KC; Cliby WA
Obstet Gynecol; 2006 Jan; 107(1):77-85. PubMed ID: 16394043
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of E-cadherin in patients with advanced serous ovarian cancer.
Bačić B; Haller H; Mrklić I; Košta V; Čarić A; Tomić S
Arch Gynecol Obstet; 2013 Jun; 287(6):1219-24. PubMed ID: 23269354
[TBL] [Abstract][Full Text] [Related]
6. The effect of centralization of primary surgery on survival in ovarian cancer patients.
Tingulstad S; Skjeldestad FE; Hagen B
Obstet Gynecol; 2003 Sep; 102(3):499-505. PubMed ID: 12962932
[TBL] [Abstract][Full Text] [Related]
7. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study.
Tetsche MS; Dethlefsen C; Pedersen L; Sorensen HT; Norgaard M
BMC Cancer; 2008 Jan; 8():31. PubMed ID: 18230177
[TBL] [Abstract][Full Text] [Related]
8. Pre-operative serum level of tumour-associated trypsin inhibitor and residual tumour size as prognostic indicators in Stage III epithelial ovarian cancer.
Venesmaa P; Stenman UH; Forss M; Leminen A; Lehtovirta P; Vartiainen J; Paavonen J
Br J Obstet Gynaecol; 1998 May; 105(5):508-11. PubMed ID: 9637119
[TBL] [Abstract][Full Text] [Related]
9. Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group).
Wimberger P; Wehling M; Lehmann N; Kimmig R; Schmalfeldt B; Burges A; Harter P; Pfisterer J; du Bois A
Ann Surg Oncol; 2010 Jun; 17(6):1642-8. PubMed ID: 20165986
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of ovarian cancer subsequent to venous thromboembolism: a nationwide Danish cohort study.
Tetsche MS; Nørgaard M; Pedersen L; Lash TL; Sørensen HT
BMC Cancer; 2006 Jul; 6():189. PubMed ID: 16846496
[TBL] [Abstract][Full Text] [Related]
11. Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients.
Dorn J; Schmitt M; Kates R; Schmalfeldt B; Kiechle M; Scorilas A; Diamandis EP; Harbeck N
Clin Cancer Res; 2007 Mar; 13(6):1742-8. PubMed ID: 17363527
[TBL] [Abstract][Full Text] [Related]
12. Survival of ovarian cancer patients in Denmark: Results from the Danish gynaecological cancer group (DGCG) database, 1995-2012.
Edwards HM; Noer MC; Sperling CD; Nguyen-Nielsen M; Lundvall L; Christensen IJ; Høgdall C
Acta Oncol; 2016 Jun; 55 Suppl 2():36-43. PubMed ID: 27355258
[TBL] [Abstract][Full Text] [Related]
13. Stage III and IV ovarian cancer in the South West of England: five-year outcome analysis for cases treated in 1998.
Bailey J; Murdoch J; Anderson R; Weeks J; Foy C
Int J Gynecol Cancer; 2006; 16 Suppl 1():25-9. PubMed ID: 16515563
[TBL] [Abstract][Full Text] [Related]
14. Predictors of 1- and 2-year mortality in patients with rectal cancer.
Quintana JM; González N; Lázaro S; Baré M; Fernández-de-Larrea N; Redondo M; Briones E; Escobar A; Sarasqueta C; García-Gutierrez S; Antón-Ladislao A;
Colorectal Dis; 2018 Aug; 20(8):676-687. PubMed ID: 29745479
[TBL] [Abstract][Full Text] [Related]
15. Poor Prognostic Factors in Patients Undergoing Surgery After Neoadjuvant Chemotherapy for Ovarian, Tubal, or Peritoneal Cancer.
Kaban A; Topuz S; Saip P; Sozen H; Celebi K; Salihoglu Y
J Obstet Gynaecol Can; 2017 Dec; 39(12):1163-1170. PubMed ID: 28784563
[TBL] [Abstract][Full Text] [Related]
16. Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT).
Karlsen NMS; Karlsen MA; Høgdall E; Nedergaard L; Christensen IJ; Høgdall C
Gynecol Oncol; 2016 Jul; 142(1):50-53. PubMed ID: 27168006
[TBL] [Abstract][Full Text] [Related]
17. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
Boorjian SA; Kim SP; Tollefson MK; Carrasco A; Cheville JC; Thompson RH; Thapa P; Frank I
J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198
[TBL] [Abstract][Full Text] [Related]
18. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.
Harter P; du Bois A; Hahmann M; Hasenburg A; Burges A; Loibl S; Gropp M; Huober J; Fink D; Schröder W; Muenstedt K; Schmalfeldt B; Emons G; Pfisterer J; Wollschlaeger K; Meerpohl HG; Breitbach GP; Tanner B; Sehouli J; ;
Ann Surg Oncol; 2006 Dec; 13(12):1702-10. PubMed ID: 17009163
[TBL] [Abstract][Full Text] [Related]
19. Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer.
Black D; Iasonos A; Ahmed H; Chi DS; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2007 Oct; 107(1):66-70. PubMed ID: 17614125
[TBL] [Abstract][Full Text] [Related]
20. Centralized treatment of advanced stages of ovarian cancer improves survival: a nationwide Danish survey.
Fagö-Olsen CL; Høgdall C; Kehlet H; Christensen IJ; Ottesen B
Acta Obstet Gynecol Scand; 2011 Mar; 90(3):273-9. PubMed ID: 21306310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
